Evidence reviewed: 8 November 2026. Melanoma is a potentially serious cancer arising from pigment-producing cells called melanocytes. It may look like a new spot or a changing mole, but not every melanoma is dark, large or painful. Detecting a suspicious lesion and arranging a timely professional skin examination is important because treatment is generally more effective before cancer spreads. The ABCDE rule is a useful visual warning-sign guide, not a diagnostic test; a melanoma can lack several of its features and can occur in people of any skin tone [1–3].
What is melanoma?
Melanocytes produce melanin, the pigment found in skin and certain other tissues. Melanoma develops when cells acquire changes that allow uncontrolled growth and invasion. Ultraviolet (UV) radiation from sunlight or tanning beds is an important preventable risk factor for many melanomas, but not every melanoma is caused by sun exposure. Some occur on the palms, soles or beneath nails, locations that may receive little UV exposure [1,2].
Melanoma is different from basal cell carcinoma and cutaneous squamous cell carcinoma, other common skin cancers. Treatment and prognosis depend on the exact diagnosis and stage. A new lesion that bleeds or does not heal deserves assessment even if it does not look like a classic dark mole.
The ABCDE rule: five changes to look for
| Letter | Warning sign | What to notice |
|---|---|---|
| A — Asymmetry | One half does not match the other | Unequal shapes or pigment distribution. |
| B — Border | Irregular, scalloped or poorly defined outline | Edges that are uneven or difficult to distinguish from nearby skin. |
| C — Color | More than one color or uneven pigmentation | Different brown, black, red, white, blue or pink regions. |
| D — Diameter | Often greater than about 6 mm | Important: melanoma can be smaller than 6 mm; size alone cannot rule it out. |
| E — Evolving | A new or changing lesion | Increase or change in size, shape, color, texture, symptoms, itching or bleeding. |
These criteria are recommended by the American Academy of Dermatology (AAD) to prompt assessment [1]. Evolution over time is particularly important. A spot that changes over weeks or months, bleeds without clear injury or looks unusual compared with other moles warrants evaluation.
The ‘ugly duckling’ sign
Many people have several harmless moles with similar features. An “ugly duckling” lesion is one that looks noticeably different from the person’s other spots—even if it is fairly small or has a relatively regular border. It might be unusually dark, unusually light or otherwise unlike nearby moles. This sign complements ABCDE, particularly in people with many moles [1,3].
A changing lesion should be reviewed even if the diameter is below 6 mm or the color appears mostly uniform. The rule is a screening prompt, not a numerical score that proves a lesion is benign.
Not all melanomas follow the ABCDE pattern
Some nodular melanomas may develop quickly and look like a relatively symmetrical, firm, raised nodule rather than a broad irregular mole. The supplementary EFG clues—Elevated, Firm and Growing—can encourage assessment of an enlarging lump. Pink, red or skin-colored (amelanotic) melanomas may have little obvious dark pigment and may resemble a pimple or another benign growth [1].
Other warning signs include persistent bleeding, crusting, a wound that does not heal, itching or a new pigmented streak beneath a nail. None of these features is exclusive to melanoma, but persistent or unexplained changes should be evaluated.
Melanoma on darker skin: important locations
People of every skin color can develop melanoma. In darker skin tones, melanoma can occur on soles, palms, between toes, around or beneath nails and other areas with limited sun exposure. The AAD advises checking these areas rather than assuming sun-protected skin cannot develop cancer [2].
Acral lentiginous melanoma can involve palms, soles and nail units. A dark patch on a sole may resemble a bruise or callus; a new or changing nail streak may be misattributed to trauma. The fact that a patch is not sun-exposed or does not hurt should never be used to dismiss a persistent suspicious lesion.
What nail changes might be concerning?
According to AAD guidance, possible signs of nail-unit melanoma include:
- A new or changing dark vertical line within a fingernail or toenail.
- Darkening of the skin around the nail fold.
- Nail splitting, lifting or distortion without a clear explanation.
- A growing or persistent bump beneath a nail, especially with altered pigmentation [4].
Many nail streaks are benign, especially in people with naturally pigmented nail bands, and injury or fungal infection can also alter nails. Nevertheless, a single newly developing, widening or irregular band needs professional assessment. Do not repeatedly cover a changing nail streak with polish while postponing evaluation.
How to check your skin at home
A self-examination helps you become familiar with your own spots and notice change, but is not a substitute for professional evaluation of something suspicious. The AAD suggests checking the whole body using mirrors and asking for help with difficult-to-see areas [3].
- Examine the face, ears, neck, chest and abdomen; check beneath and between skin folds as appropriate.
- Look at the back, shoulders, backs of arms and legs using a hand mirror or another person.
- Check scalp and hairline, parting the hair to see the skin.
- Inspect palms, soles, between fingers and toes, fingernails and toenails.
- Note new, changing or symptomatic lesions and compare with previously taken images if available.
Taking a photograph with a ruler for scale may help communicate change, but camera color, lighting or an app cannot rule out melanoma. Avoid trying to diagnose or remove a suspicious growth at home.
Who has a higher risk of melanoma?
- Excessive intermittent UV exposure, especially blistering sunburns and tanning-bed use.
- Personal history of melanoma or some other skin cancers.
- Family history of melanoma, especially multiple affected relatives.
- Numerous or atypical moles, certain inherited susceptibility variants or immunosuppression.
- Light skin that burns easily and certain pigmentation traits, although melanoma can occur with any skin color.
Risk varies substantially, and a lesion’s appearance still matters even when the person has no recognized risk factors. People with a prior melanoma or a strong genetic predisposition often need specialist surveillance tailored to their risk [1,3].
How is a suspicious lesion diagnosed?
A dermatologist performs a focused clinical examination and may use dermoscopy, a magnifying, illuminated method for examining skin structures. Dermoscopy can improve lesion assessment when used by trained clinicians, but it does not replace histological confirmation when melanoma is suspected. The standard next step is usually a biopsy, with the procedure selected to obtain enough tissue for accurate diagnosis and staging [5].
When feasible, a clinician may perform complete full-thickness excisional biopsy with a narrow clinical margin for a suspicious lesion. For large, facial, acral or nail-unit lesions, a different carefully planned biopsy approach may be necessary. Do not remove or freeze an unexplained mole at home or allow cosmetic destruction of a suspicious lesion without pathology. Destruction can delay diagnosis and prevent assessment of tumor depth.
What does the pathology report tell clinicians?
Pathology confirms whether the lesion is melanoma and describes relevant features such as Breslow thickness (how deeply tumor extends), ulceration and other characteristics. These findings help determine stage and next steps. A pathology report may distinguish melanoma in situ, which is confined to the epidermis, from invasive melanoma [5].
Depending on tumor depth, ulceration and other features, the team may discuss sentinel lymph node biopsy to evaluate microscopic spread to nearby nodes. This procedure is not needed for every thin melanoma. The National Cancer Institute describes consideration in selected melanomas, including tumors approximately 0.8 mm or thicker or thinner tumors with other high-risk features [5]. Exact recommendations depend on current protocols and specialist assessment.
How is melanoma treated?
| Clinical situation | Common treatment approach |
|---|---|
| Localized early melanoma | Appropriate surgical excision with margins chosen based on histology and location. |
| Selected higher-risk localized or regional disease | Surgery, possible sentinel node assessment and consideration of adjuvant or neoadjuvant systemic therapy in eligible patients. |
| Unresectable or metastatic disease | Specialist systemic options may include immune checkpoint inhibitors and, for appropriate mutations, targeted therapy. |
| BRAF V600-mutant melanoma | Selected patients may receive BRAF and MEK inhibitor combinations; genetic testing determines eligibility. |
The NCI summarizes stage-based treatment options. Anti-PD-1 immunotherapies such as pembrolizumab or nivolumab and other checkpoint combinations can offer benefit in selected patients but can cause serious immune-related adverse effects. Targeted treatment requires relevant mutations and is not suitable for every melanoma. Screening signs cannot determine which cancer therapy to choose [5].
Sun protection that reduces UV exposure
To lower preventable UV damage:
- Seek shade during periods of strong UV exposure and check the local UV index.
- Use broad-spectrum, water-resistant sunscreen with SPF 30 or higher on exposed skin, applying adequately and reapplying according to the product label, especially after swimming or sweating.
- Wear protective clothing, a wide-brimmed hat and suitable sunglasses.
- Avoid tanning beds and deliberate sunburn.
- Continue checking for new or changing lesions, including sun-protected areas and nails [2,3].
Sunscreen reduces UV exposure; it does not make unrestricted sunbathing safe or eliminate melanoma risk. Sun protection is appropriate for every skin tone, even though risks and patterns of melanoma differ across populations.
Do all adults need an annual full-body skin screening?
The US Preventive Services Task Force (USPSTF) concluded in 2023 that evidence is insufficient to determine the balance of benefits and harms of routine clinician skin-cancer screening in asymptomatic, average-risk adolescents and adults [6]. This is not a recommendation against examining a suspicious lesion, nor does it apply to people with a personal skin-cancer history or high-risk surveillance needs.
If you notice a changing, bleeding or unusual spot, arrange a clinician assessment. Someone with previous melanoma, strong family history or numerous atypical lesions may require a tailored skin-check schedule recommended by a dermatologist.
Frequently asked questions
Can a melanoma be smaller than 6 mm?
Yes. The D in ABCDE is a warning clue, not a minimum size for cancer [1].
Can melanoma be pink rather than black?
Yes. Some melanomas have little pigment and may be pink, red or skin-colored.
Can people with dark skin get melanoma?
Yes, including on palms, soles and nail units; lower UV exposure does not exclude cancer [2].
Does a mole need to itch or bleed to be dangerous?
No. Many melanomas cause no pain or discomfort; change and unusual appearance are important signs.
Can a phone app diagnose a mole?
No. Apps and photographs cannot reliably replace a dermatologist’s examination and appropriate biopsy.
Can sunscreen replace checking my skin?
No. Preventing UV exposure and recognizing suspicious changes are complementary strategies.
Key takeaways
Remember ABCDE, the ugly-duckling sign and new or changing nail or sole lesions. Melanoma may be small, pink or painless. Prompt clinical examination and biopsy are essential for suspicious growths; pathology—not photographs alone—determines diagnosis and guides treatment.
References
- American Academy of Dermatology. Melanoma: signs and symptoms and the ABCDE rule. Accessed 8 Nov 2026.
- American Academy of Dermatology. Finding skin cancer in darker skin tones. Accessed 8 Nov 2026.
- American Academy of Dermatology. How to perform a skin self-examination. Accessed 8 Nov 2026.
- American Academy of Dermatology. How to check your nails for melanoma. Accessed 8 Nov 2026.
- National Cancer Institute. Melanoma treatment (PDQ): health professional summary. Accessed 8 Nov 2026.
- US Preventive Services Task Force. Skin cancer: screening recommendation statement. April 2023.
Medical disclaimer: Educational material only. A suspicious or changing lesion requires assessment by a qualified clinician. This article cannot diagnose skin cancer or choose treatment; do not use home freezing or removal products on unexplained lesions.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.